Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
6
75%
Ph early_phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
66.7%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

terminated225%
not_yet_recruiting113%
unknown113%
completed450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8